Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely (Lead / Corresponding author), Olav Dalgard, Brian Conway, Evan B. Cunningham, Philip Bruggmann, Behzad Hajarizadeh, Janaki Amin, Julie Bruneau, Margaret Hellard, Alain H. Litwin, Philippa Marks, Sophie Quiene, Sharmila Siriragavan, Tanya L. Applegate, Tracy Swan, Jude Byrne, Melanie Lacalamita, Adrian Dunlop, Gail V. Matthews, Jeff PowisDavid Shaw, Maria Christine Thurnheer, Martin Weltman, Ian Kronborg, Curtis Cooper, Jordan J. Feld, Chris Fraser, John F. Dillon, Phillip Read, Ed Gane, Gregory J. Dore, on behalf of the SIMPLIFY Study Group

Research output: Contribution to journalArticlepeer-review

132 Citations (Scopus)
439 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial'. Together they form a unique fingerprint.

Medicine & Life Sciences